COMPANY

Promiliad Biopharma Incorporated

HQ: Alberton, MT source · promiliad.com ↗ · Mountain

Location: Alberton, MT · source · Oct 14, 2026

Profile checked Oct 10, 2026

18NIH grants

NIH awards 18

Annual award amounts. Total $7.5M.

Aug 5, 2021 NIH award 5R42DC017641-03 FY2021: $696,062 awarded for that fiscal year; activity R42 (STTR); PI SERBAN, MONICA ANDREA; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Single application thixotropic an source ↗
Sep 1, 2020 NIH award 2R42DC017641-02A1 FY2020: $751,069 awarded for that fiscal year; activity R42 (STTR); PI SERBAN, MONICA ANDREA; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Single application thixotropic source ↗
Mar 10, 2020 NIH award 5R42AI118104-03 FY2020: $750,375 awarded for that fiscal year; activity R42 (STTR); PI PRIESTLEY, NIGEL D; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Novel antibacterial agents derived f source ↗
Apr 3, 2019 NIH award 2R42AI118104-02 FY2019: $746,516 awarded for that fiscal year; activity R42 (STTR); PI PRIESTLEY, NIGEL D; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Novel antibacterial agents derived f source ↗
Aug 30, 2018 NIH award 1R41DC017641-01 FY2018: $297,825 awarded for that fiscal year; activity R41 (STTR); PI SERBAN, MONICA ANDREA; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Single application thixotropic an source ↗
Jul 14, 2016 NIH award 1R41AI118104-01A1 FY2016: $295,729 awarded for that fiscal year; activity R41 (STTR); PI PRIESTLEY, NIGEL D; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Novel antibacterial agents derived source ↗
Jun 1, 2013 NIH award 1R43AI106166-01A1 FY2013: $287,766 awarded for that fiscal year; activity R43 (SBIR); PI PRIESTLEY, NIGEL D; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Development of stable isosteres of source ↗
Jul 8, 2011 NIH award 5R42AI065143-03 FY2011: $763,661 awarded for that fiscal year; activity R42 (STTR); PI WRIGHT, DENNIS L.; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Potent Antifolates as New Therapeutic source ↗
Jun 11, 2010 NIH award 2R42AI065143-02A1 FY2010: $754,203 awarded for that fiscal year; activity R42 (STTR); PI WRIGHT, DENNIS L.; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Potent Antifolates as New Therapeut source ↗
Jul 10, 2009 NIH award 1R43AI077245-01A1 FY2009: $171,569 awarded for that fiscal year; activity R43 (SBIR); PI PRIESTLEY, NIGEL; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. New antibiotics targeting fatty acid source ↗
Jun 30, 2009 NIH award 3R41DA026245-01S1 FY2009: $41,940 awarded for that fiscal year; activity R41 (STTR); PI MCKAY, DENNIS BRIAN; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. The identification of novel negati source ↗
May 5, 2009 NIH award 1R41DA026245-01 FY2009: $190,807 awarded for that fiscal year; activity R41 (STTR); PI MCKAY, DENNIS BRIAN; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. The identification of novel negativ source ↗
Jul 9, 2008 NIH award 1R43AI078646-01 FY2008: $225,624 awarded for that fiscal year; activity R43 (SBIR); PI PRIESTLEY, NIGEL D; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Isoindolinones as Antimicrobial Agen source ↗
Apr 30, 2007 NIH award 5R42GM072158-03 FY2007: $481,066 awarded for that fiscal year; activity R42 (STTR); PI WRIGHT, DENNIS L; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Natural feedstocks for diversity-orien source ↗
Jul 30, 2006 NIH award 1R41AI065143-01A2 FY2006: $279,271 awarded for that fiscal year; activity R41 (STTR); PI WRIGHT, DENNIS L; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Potent and selective DHFR inhibitors source ↗
Apr 28, 2006 NIH award 2R42GM072158-02 FY2006: $517,214 awarded for that fiscal year; activity R42 (STTR); PI WRIGHT, DENNIS L; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Natural feedstocks for diversity-orien source ↗
Jul 15, 2005 NIH award 1R41AI060249-01A2 FY2005: $137,162 awarded for that fiscal year; activity R41 (STTR); PI BERGMEIER, STEPHEN C; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Fermentation initiated antibioti source ↗
Aug 27, 2004 NIH award 1R41GM072158-01 FY2004: $100,024 awarded for that fiscal year; activity R41 (STTR); PI WRIGHT, DENNIS L; recipient as written: PROMILIAD BIOPHARMA, INC., ALBERTON, MT. Natural feedstocks for diversity orien source ↗